英文名稱 | Fexinidazole (HOE 239) |
---|---|
中文名稱 | 非昔硝唑 |
CAS號(hào) | 59729-37-2 |
分子式 | C12H13N3O3S |
分子量 | 279.31 |
外觀 | Light yellow to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Fexinidazole (HOE 239) |
---|---|
中文名稱 | 非昔硝唑 |
CAS號(hào) | 59729-37-2 |
分子式 | C12H13N3O3S |
分子量 | 279.31 |
外觀 | Light yellow to yellow powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense. It acts well against diseases in both their initial and advanced stages. Its use in Chagas disease is also supported by some evidence.